Literature DB >> 34790632

A Case of Severe COVID-19 in a Patient with Good's Syndrome.

Maria Duarte1, Luciana Faria1, Catarina Patronillo1, Sónia da Costa Fernandes1, Vera Seara1.   

Abstract

Good's syndrome is a rare adult-onset combined immunodeficiency. The association of hypogammaglobulinaemia with a history of recurrent infectious or autoimmune manifestations in a middle-aged patient with evidence of a mediastinal mass should lead to the clinical suspicion of Good's syndrome. The mortality rate associated with infectious complications is high. Thus, although it is rare, the disease should be diagnosed early so that proper treatment can be started. Thymectomy and immunoglobulin replacement are the main therapeutic strategies. We describe the case of a patient with a history of thymoma and recurrent respiratory infections, with a late diagnosis of Good's syndrome in the context of severe organizing pneumonia secondary to COVID-19. LEARNING POINTS: Infection is the leading cause of mortality in patients with Good's syndrome.Early recognition of this rare disease and substitutive therapy with immunoglobulin may have an important impact on prognosis.Due to its rarity, data on Good's syndrome are scarce and its association with severe COVID-19 onset is still unclear.To the best of our knowledge, this is the fifth case report of COVID-19 in a patient with Good's syndrome, the third with a favourable outcome. © EFIM 2021.

Entities:  

Keywords:  COVID-19; Good’s syndrome; immunoglobulin

Year:  2021        PMID: 34790632      PMCID: PMC8592660          DOI: 10.12890/2021_002976

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  8 in total

1.  [COVID-19 in adults with antibody deficiencies].

Authors:  Ana Laura López; María Gabriela Torre; María Virginia Paolini; María Cecilia Juri; Diego S Fernández Romero
Journal:  Medicina (B Aires)       Date:  2021       Impact factor: 0.653

2.  Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective.

Authors:  Anne Jansen; Marcel van Deuren; Joanne Miller; Jiri Litzman; Javier de Gracia; Matías Sáenz-Cuesta; Anna Szaflarska; Timi Martelius; Yuichi Takiguchi; Smita Patel; Siraj Misbah; Anna Simon
Journal:  Clin Immunol       Date:  2016-08-04       Impact factor: 3.969

Review 3.  Immunodeficiency and thymoma in Good syndrome: Two sides of the same coin.

Authors:  Kissy Guevara-Hoyer; Jesús Fuentes-Antrás; Joaquín Calatayud Gastardi; Silvia Sánchez-Ramón
Journal:  Immunol Lett       Date:  2021-01-05       Impact factor: 3.685

4.  Good's syndrome, a rare form of acquired immunodeficiency associated with thymomas.

Authors:  Antonio Tamburello; Laura Castelnovo; Paola Faggioli; Daniela Bompane; Bruno Brando; Arianna Gatti; Lucia Roncoroni; Biancamaria Di Marco; Antonino Mazzone
Journal:  Clin Pract       Date:  2019-06-05

5.  Severe COVID-19 pneumonia in Good syndrome with a favorable outcome.

Authors:  Maria Lourdes Cos Esquius; Inmaculada López Montesinos; Ramón Gimeno Martinez; Jorge Eguía Núñez; M Araceli Caballero-Rabasco; Blanca Sánchez González; Alicia López García; Leonardo Mellibovsky
Journal:  Clin Immunol       Date:  2021-06-29       Impact factor: 3.969

6.  When the Good Syndrome Goes Bad: A Systematic Literature Review.

Authors:  Yiyun Shi; Chen Wang
Journal:  Front Immunol       Date:  2021-05-25       Impact factor: 7.561

7.  Humoral Immunity in Bronchiectasis: Finding Good's Syndrome.

Authors:  C Pu; S Sukhal; S Fakhran
Journal:  Case Rep Pulmonol       Date:  2015-12-29

8.  Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy.

Authors:  Jonathan London; David Boutboul; Karine Lacombe; France Pirenne; Beate Heym; Valérie Zeller; Antoine Baudet; Amani Ouedrani; Alice Bérezné
Journal:  J Clin Immunol       Date:  2020-11-20       Impact factor: 8.317

  8 in total
  1 in total

Review 1.  COVID-19 and Inborn Errors of Immunity.

Authors:  Ottavia M Delmonte; Riccardo Castagnoli; Luigi D Notarangelo
Journal:  Physiology (Bethesda)       Date:  2022-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.